Size: px
Start display at page:

Download ""

Transcription

1 Opioid Addiction: The Cure Sanford Silverman, MD Medical Director, Comprehensive Pain Medicine, Pompano Beach, FL Member: ASIPP, DAPM, FSIPP, DABAM, FSAM, FMA, BCMA Officer/Board Position: President FSIPP, Broward County Commission on Substance Abuse, Board of Directors BCMA, Assistant Clinical Professor, Dept. Surgery NOVA Southeastern University Expert Medical Advisor FL WC Publications: Articles in Anesthesiology, Canadian Journal of Anesthesia, Pain Physician No Commercial bias or disclaimer for this presentation Discuss definition of Addiction as diseases Define terms of Addiction, Dependence, Tolerance, Chemical Coping Epidemiology of prescription drug abuse Discuss good prescribing practices for opioids Discuss implementation of opioid guidelines and the identification of opioid abuser v. chronic pain patient Discuss specific risk management tools utilized for opioid therapy And Noah planted a vineyard. And he drank of the wine, and became drunken. And he was naked and dirty in his tent. And Ham saw the nakedness and filthy condition of his father, and told his two brothers. And Shem and Japheth took a garment...and covered the nakedness of their father; and they turned their faces away, so as to avert their eyes from their father's nakedness and shame. Ancient Sumeria c 3400 BC Egyptians 1300 BC Hippocrates 460 BC Pain killing narcotic Euphoria- recreational Very popular among 19 th century writers John Keats Elizabeth Barrett Browning - Genesis 9:

2 ~ 30,000,000 chemical compounds are known (Chemical Abstracts substance count) ~ 100 are addictive Nicotine Alcohol Psychostimulants (cocaine, amphetamines) Opiates Cannabinoids Barbiturates Benzodiazepines Many drugs produce physical dependence without addiction Caffeine, SSRI s Some drugs produce addiction without physical dependence Cocaine, Amphetamine Animals take addicting drugs in absence of physical dependence Pain significantly reduces addictive liability (maybe) Brain sites of addiction differ from brain sites that mediate physical dependence a primary, chronic, neurobiological disease, with genetic, psychosocial, and environmental factors influencing the development and manifestations. It is characterized by behaviors that include one or more of the following: Impaired Control over drug use Compulsive use Continued use despite harm Craving (ASAM, 2001) Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leads to characteristic biological, psychological, social and spiritual manifestations. This is reflected in an individual pathologically pursuing reward and/or relief by substance use and other behaviors. Addiction is characterized by inability to consistently abstain, impairment in behavioral control, craving, diminished recognition of significant problems with one s behaviors and interpersonal relationships, and a dysfunctional emotional response. Like other chronic diseases, addiction often involves cycles of relapse and remission. Without treatment or engagement in recovery activities, addiction is progressive and can result in disability or premature death. Adopted by the ASAM Board of Directors 4/12/2011.

3 PHYSICAL DEPENDENCE: Pharmacologic effect characteristic of opioids; withdrawal or abstinence syndrome manifest on abrupt cessation of medication TOLERANCE: Pharmacologic effect characteristic of opioids; need to increase dose to achieve the same effect or diminished effect from the same dose PSEUDO-ADDICTION: Pattern of drug-seeking behavior of pain patients receiving inadequate pain management that can be mistaken for addiction; resolves with re-establishing analgesia CHEMICAL COPING: Behavior bears a resemblance to addiction because pill -taking is inappropriately used to manage stress PSEUDOTOLERANCE: Is the need to increase dosage not due to tolerance, but due to other factors such as disease progression, new disease, increased physical activity, lack of compliance, change in medication, drug interaction, addiction, and deviant behavior. Stimulator

4 The Hijacked Brain Hypothesis Addictive drugs act on the same brain-reward substrates and mechanisms as do natural biologically-essential rewards (e.g., food, sex, etc) Addictive drugs derive much of their addictive power by activating these brain-reward substrates and mechanisms more powerfully than natural biologically-essential rewards (e.g., food, sex, etc) Experimental evidence for this Progressive Ratio Self Administration Designed to progressively increase the workload on the experimental animal i.e. first push yields injection, then requires 2 pushes for injection, then 4, 8, 16, 32 Break point is defined as the ratio when the animal will abruptly STOP pushing to get injection Progressive Ratio Self Administration Break point Intravenously administered by Rhesus Monkey Diazepam 10:1 Morphine 200:1 Heroin 500:1 Cocaine 10,000:1 Progression of the disease of Addiction Recreational occasional use Recreational steady use Reward-driven use Habit-driven use No longer rewarding or only with first use of day Transition from ventral striatum to dorsal striatum Habit-driven use Compulsive use Denial, the Crash, Bottoming Out Treatment and achievement of abstinence Persistent vulnerability to craving and relapse Opioid withdrawal Neurochemistry - Autonomic withdrawal Opioids acutely depress NE activity in locus coeruleus Tolerance develops with chronic use and UPREGULATION of central noradrenergic activity,distal site Decreased efficacy (less analgesia) at local site of receptor (uncoupling, protein kinase) Withdrawal results in increased BP, HR, peristalsis, diaphoresis, and increased CNS irritability Opioid withdrawal Neurochemistry - Affective withdrawal Opioids acutely RAISE dopamine levels in mesolimbic pathway Tolerance develops with chronic use and DA transmission DECREASES over time Withdrawal results in anhedonia, dysphoria, depression, and anxiety

5 This is your Brain on Drugs Role of Dopamine Dopaminergic fibers in the reward/reinforcement circuitry appears to be the crucial addictive-drug-sensitive component. ALL addictive drugs have in common that the ENHANCE dopaminergic function at crucial dopamine reward synapses in the nucleus accumbens. Dopamine mediates the hedonic consequences of a reinforcing stimulus, promoting associative learning about the stimulus or anticipating its rewarding effects A physician understands risks and management of addictive disease. Persistent failure to treat addiction is poor medical practice Failure to prescribe opioids when indicated is also poor medical practice Physicians traditionally receive little or no education about pain management or the treatment of addiction.

6 Pain is undertreated Fear of patient harm Fear of regulatory, legal or licensing penalties Addictive disorder or risk for addiction Divert or misuse of medications Lack of Awareness <20% received any medical school training in identifying prescription drug diversion <40% received any training in medical school in identifying prescription drug abuse and addiction Inadequate Risk Management 43% do not ask about prescription drug abuse as part of patient history 33% do not request records from previous health care providers for new patients Inadequate Treatment of Patients 74% have not prescribed a controlled substance due to concern about patient abuse in the past year New era s Undertreatment of pain common Analgesia-induced addiction rare 1997 American Academy of Pain and American Pain Society advised all types of clinicians to consider the use of opioids in chronic pain patients BECAUSE THE RISK OF ADDICTION WAS LOW IN PAIN PATIENTS!! Liberal use of opioids for chronic nonmalignant pain Restricted use of opioids for chronic non-malignant pain. Use for cancer pain Boston Collaborative Drug Surveillance Project: 4 of 11,882 patients Survey of burn centers: 0 of 10,000 patients Survey of headache center: 3 of 2,369 patients Addiction rare in cancer and noncancer populations THEY WERE WRONG!! (Porter, 1980; Perry, 1982; Medina, 1977; Moulin, 1996)

7 Annual Numbers of New Nonmedical Users of Pain Relievers, by Age at Initiation: , SAMHSA Oxycodone Hydrocodone Methadone 51,225 (32%) 41,216 (25.7%) 42,810 (26.7%) 15,183 (9.5%) 9,160 (5.7%) Fentanyl Morphine Total = 598,542 Narcotic analgesics alone = 160,363 Adapted from the Drug Abuse Warning Network. DHHS Publication No , out of 3 visits were from nonmedical use of opioid analgesics in Of these, oxycodone and hydrocodone account for about 60%. Florida 9,201,731 Dose Units

8 Criminal Justice 17% Workplace 53% $4.6 billion $1.4 billion $2.6 billion Health Care 30% Total cost of prescription opioid abuse in the United States was $8.6 billion in 2001 and continues to grow. Birnbaum HG et al. Clin J Pain. 2006;22: Risk Management Strategies: The Cure? OPIOID THERAPY FOR CHRONIC PAIN? Efficacy Goal of therapy is pain relief and improved function Safety Predictable pharmacokinetics Evaluate interaction with alcohol GOOD PRACTICE Abuse Potential Long vs short acting Level of difficulty to alter delivery system Street value

9 Pain and Addiction Problem Pain and Addiction CAN coexist Addiction in General Population (6-15%) Varies with the drug, gender, economic status, race Addiction in Chronic Pain Population Probably increased (at least 15%) We use the same terms, with different meaning Lack of precision in definitions around abuse/dependency/addiction Sedatives Alcohol, benzodiazepines, barbiturates OTC product (Dramamine,Benadryl /dextromethoraphan) Withdrawal causes anxiety, insomnia, seizures Stimulants Cocaine, methamphetamine, amphetamines, methylphenidate Withdrawal causes profound depression Opioids Short acting (IR/CR) Long acting (methadone / bupenorphine) Withdrawal causes hyperadrenergic state, typically NOT seizures Hyperalgesia due to opioid abstinence syndrome AND high dose opioid therapy More Predictive Selling prescription drugs Prescription forgery Stealing or borrowing another patient s medications Injecting oral formulation Obtaining prescription drugs from non-medical sources Concurrent abuse of related illicit drugs Multiple unsanctioned dose escalations Recurrent prescription losses Less Predictive Drug hoarding during periods of reduced symptoms Requesting specific drugs Acquisition of similar drugs from other medical sources Unsanctioned dose escalation 1-2 times Unapproved use of the drug to treat another symptom Reporting psychic effects not intended by the physician Aggressive complaining about need for higher doses Misuse 40% Abuse: 20% Addiction: 2% to 5% Webster LR, Webster RM. Pain Med. 2005;6(6): Total Pain Population Low Risk Moderate Risk High Risk No past/current history of substance abuse Noncontributory family history of substance abuse No major or untreated psychological disorder History of treated substance abuse Significant family history of substance abuse Past/comorbid psychological disorder Active substance abuse Active addiction Major untreated psychological disorder Significant risk to self and practitioner LOW < 1% Short term exposure to opioids No history of addiciton HIGH 15-45% Long term exposure to opioids History of addiction Aberrant behaviors Unresponsive to opioid therapy WHERE IS YOUR PATIENT? Webster LR, Webster RM. Pain Med. 2005;6: Passik, 1998

10 The 5 D s Dated: doctors who have not kept up with standards of practice Duped: doctors easily manipulated by addicts, perhaps of difficulty in confronting patients, pride Disabled: doctors who are impaired by illness or chemical dependency Dishonest: doctors who willfully prescribe and use their licenses to deal drugs Denial: doctors who refuse to admit that they are wrong, I know what I am doing Risk management is a process of Assessing a product s risk-benefit balance Developing strategies and implementing tools to minimize risk and preserve benefits for the patient and the clinician Reassessing a product s benefit-risk balance and evaluating tool effectiveness Adjusting, as appropriate, the risk-minimization tools to further improve the benefit-risk balance Adapted from US Food and Drug Administration. Guidance for industry development and use of risk minimization action plans. March Risk Management Is a Shared Responsibility Health Care Providers Risk assessment Individualized therapy Patient/caregiver education Adherence monitoring Case Management Communication with provider Regulatory/Law Enforcement Patients Compliance and adherence Preventing theft Following pain treatment agreements Drug Companies Secure supply chain Tamper-resistant drug delivery Education for all (sales force to patient) Work with local, state and national agencies Pharmacies Educate patient/caregiver Vigilance for aberrant behaviors Report inappropriate prescribing Monitor drug inventory Total Population of Opioid Users and Prescribers Opioid User and Prescriber Demographics : Deciding the Future Misuser, Abuser, and Diverter Appropriately Treated Patients and Treating Prescribers Opioiphobic Patients and Prescribers Today (No RMP) Misuser, Abuser, and Diverter Appropriately Treated Patients and Treating Prescribers Opioiphobic P&P Future (No RMP) RMP = risk management plan; P&P = patients and prescribers. OR Misuser, Abuser, and Diverter Appropriately Treated Patients and Treating Prescribers Opioiphobic P&P Future (Effective RMP) High (Euphoria) X Pain Control Set realistic patient expectations for analgesia and functionality Smart goals Realistic pain control Improved functionality and productivity Improved quality of life Concomitant physical therapy to improve treatment outcomes Commit the patient to routine evaluation of treatment outcomes Adapted from Trescot AM et al. Pain Physician. 2006;9:1-40. Pain relief Physical and psychosocial function

11 Review comorbidities and pain diagnosis periodically Success continue therapy Stable doses Analgesia: decreased pain level (pain score) and increased level of function in postintervention reassessment No evidence or suspicion of abuse No unmanageable side effects Improved activity and quality of life Failure discontinue therapy Despite dose escalation or switching to other opioids Inadequate analgesia Inadequate improvement in function Intolerable side effects Abuse Noncompliance Hyperalgesia 1981 US Department of Defense instituted periodic and random drug testing of all servicemen Nearly 80% Fortune 500 companies were conducting pre-employment drug testing Resulting from Executive Order# 12564, and congressional public law # Department of Health and Human Service Guidelines publishedrequire a licensed physician to be responsible MRO s are born!, DOT involved by Adapted from Trescot AM et al. Pain Physician. 2006;9:1-40. Study I (2003) 1 Study II (2006) 2 Patients Abusing Controlled Substances (%) % No Adherence Monitoring N = 500 N = 500 9% Adherence Monitoring 1. Manchikanti L et al. J KY Med Assoc. 2003;101: Manchikanti L et al. Pain Physician. 2006;9: Make sure it IS what it says Get confirmatory analysis Make appropriate referral for addiction issues Take appropriate action for DIVERSION Appears inappropriate in my medical judgment Problem requires evaluation prior to symptomatic treatment are medicolegally acceptable. Request was refused isn t. If you say addict or drug seeking you must document an offer of substance abuse treatment. If you document diversion, you may report it under potential harm to self or others exemption to patient confidentiality. Psychological diagnoses must be assessed psychological or psychiatric evaluation. A second opinion should be offered when refusing to prescribe. Never refill chronic opioids at night or weekends. Take positive action when diversion or abuse are an issue Firing the patient is not positive action Recommend addiction treatment and document refusal Violate patient confidentiality for cases of diversion

12 Document every prescription and change. Document medical reason for each change. Never, ever meet a patient outside the office or hospital. Use an Opioid agreement if prescribing more than 30 days. DON T TAKE OFF IF YOU CAN T LAND!! PAIN MANAGEMENT OPIOID DISPENSING 1. Diagnosis with appropriate differential 2. Psychological assessment including risk of addictive disorders 3. Informed consent (verbal v. written/signed) 4. Treatment agreement (verballv.written/signed) 5. Pre/Post Intervention Assessment of Pain Level and Function Heit, Gourlay ASAM 2005

13 6. Appropriate trial of opioid therapy +/- adjunctive medication 7. Reassessment of pain score and level of function 8. Regularly assess the Four A s of pain medicine : Analgesia, Activity, Adverse reactions, Aberrant behavior 9. Periodically review pain diagnosis and co-morbid conditions, including addictive disorders 10. Documentation PAIN MANAGEMENT = RATIONAL POLYPHARMACY Ongoing PT, Psych, interventional mgt. If you really wanna score, you got to get into a pain clinic and stop begging for 20 Lortab from the ER. Pain docs don t t think anything about writing 100 tabs at a time, sometimes more. The best ones are just one guy or maybe two, not the big places. And don t t use headaches, that doesn t t work anymore. You can usually sell back pain if you say you were hurt a long time ago. Or if you ve had surgery tell them there s s pain way deep wherever the scar is. Tell them you don t t have insurance and are paying cash so they won t t order an MRI or nerve blocks. I tell them the doctor who used to treat me lives 1,000 miles away and has retired. Dude, I go to three different ones and get 200 Vikes, 120 Big Percs, and a bunch of Soma EVERY DAMN MONTH! Scoremore211; alt.drugs.hard, January 2003 This is important - if they straighten your leg out while you re sitting on the bed, tell them it hurts just like when they lift it while you re laying down. Scrape your gums with your fingernail hard enough to make a little blood, then when they want a urine pee over your finger. This puts enough blood in your urine to make them believe you passed a kidney stone. Put some Tabasco sauce on your finger and let it dry, then while your waiting for the doc, rub one eye and tell them that s the side the headache s s on- one look at that red eye and they always buy it. Alt.drugs.hard Oxycontin $20-80 Dilaudid $20-40 Crack $10-20 Heroin $12-20 MSIR $8-12 Percocet $8-15 Lortab $5-9 Xanax $3-7 Valium $2-4 MS Contin $ 3-12 Hydromorphone $8-15 Methadone $5-10 Oxycodone $5-8 Hydrocodone $3-7 Alprazolam $3-7 Soma $2-4 Diazepam $1-2 Roxicodone $ 15

14 Obtain pharmacy printout (subsequent visits PRN) Utilize your state s prescription monitoring system Complete history of drug/substance use Psychiatric history Pain quantifying scale (Magill, etc.) Urine drug screen Expectation of care document Agreement signed at first visit (preferably before) Summarizes clinic s treatment policies and philosophy Outlines patient s responsibilities Chronic pain is never an emergency and after hour calls will not be tolerated Opioid medication will not be prescribed at the first visit Screener and Opioid Assessment for Patients with Pain (SOAPP-R) Scored 0-4 per question > 22 = High Risk = Moderate Risk < 9 = Low Risk You Must define dependence, withdrawal, tolerance, addiction You must state that you discussed alternative therapies HAVE SPOUSE SIGN AGREEMENT Emphasize psychosocial and physical functional status as the guide Analgesia is a lesser concern Treat opioid-related side effects Look for behavioral changes suggestive of addiction development The 4 A s Analgesia Activities of daily living Adverse reactions Aberrant behavior

15 Signs: Hypertension Tachycardia Tachypnea Hyperthermia Diarrhea Mydriasis Rhinorrhea Chills Symptoms: Pain (abdominal cramps, myalgia, allodynia) Dysphoria (fear, anger) Insomnia Drug craving Must have physician-patient relationship Must have a chart with H&P Documentation of each Rx Document reason for early refills Document reason for any change in dosage Document expectation of treatment s effect Documentation of diagnosis causing pain Cannot predate Schedule II, but can use Do not fill until If prescribing for greater than 30 days, follow established principles and guidelines for chronic opioid therapy, opioid agreement etc. If patient requires opioids for greater than 30 days, get Pain Consult Monitor and document the 4 A s Be aware for signs of addiction and diversion Seek consultation when appropriate Know the street value of medications Ask about prior substance abuse Use due diligence to explore diversion Pharmacy sweeps Urine screens Alt.drugs.hard Use sustained release preparations over short acting Use of opioids may be necessary for pain relief Balanced multimodal care Treatment goals Improve independent function Improve activity level Decrease pain Apply risk management strategies Controlled substance agreement PDMP Screening tools Background checks Pill counts Urine drug testing Abuse deterrent products Communication with pharmacist Family and friend feedback Periodic reviews 89

16 91 Sanford M. Silverman, MD Comprehensive Pain Medicine 100 East Sample Rd, Suite 200 Pompano Beach, FL Phone:

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE

More information

Substance Abuse Issues in Pain Management

Substance Abuse Issues in Pain Management Substance Abuse Issues in Pain Management Steven D. Passik, PhD Associate Attending Psychologist Memorial Sloan Kettering Cancer Center New York, NY Opioid Rhetoric: From Complete Avoidance to Complete

More information

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Section I: Preamble The Michigan Boards of Medicine and Osteopathic Medicine & Surgery recognize that principles of quality

More information

Addiction Medicine for FP / GP. Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com

Addiction Medicine for FP / GP. Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com Addiction Medicine for FP / GP Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com S Disease of Chemical Addiction Short Definition of Addiction (ASAM): Addiction is a primary, chronic disease

More information

Prescription Medication Abuse: Skills for Prevention and Intervention

Prescription Medication Abuse: Skills for Prevention and Intervention Prescription Medication Abuse: Skills for Prevention and Intervention icare Partnership www.icarenc.org James Finch, MD North Carolina Society of Addiction Medicine NC Governor s Institute on Alcohol and

More information

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse?

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse? Opioid Contracts: A Tool for Providing Relief and Preventing Abuse? Jane Jurcic McMaster Family Practice and Hamilton Family Health Team Hamilton, Ontario Opioid Prescribing in Chronic Pain Legitimate

More information

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles

More information

Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain

Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain JENNIFER M. GRANHOLM GOVERNOR STATE OF MICHIGAN DEPARTMENT OF COMMUNITY HEALTH LANSING JANET OLSZEWSKI DIRECTOR Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment

More information

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate

More information

These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.

These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level. Substance-Related Disorders DSM-V Many people use words like alcoholism, drug dependence and addiction as general descriptive terms without a clear understanding of their meaning. What does it really mean

More information

CNCP and Addiction. Disclosures 17/02/2015. CPSNS CPSNL Atlantic Mentorship Network P&A. John Fraser February 18, 2015

CNCP and Addiction. Disclosures 17/02/2015. CPSNS CPSNL Atlantic Mentorship Network P&A. John Fraser February 18, 2015 CNCP and Addiction John Fraser February 18, 2015 Disclosures CPSNS CPSNL Atlantic Mentorship Network P&A "Your eyes are fine. It s just that on some eye charts the type is too small." 1 CNCP with history

More information

Guidelines for Use of Controlled Substances for the Treatment of Pain

Guidelines for Use of Controlled Substances for the Treatment of Pain 1.0 Purpose: Use of Controlled Substances for the Treatment of Pain The Physicians Advisory Committee for Controlled Substances of the Medical Society of Delaware supports the Federation of State Medical

More information

Pain, Addiction & Methadone

Pain, Addiction & Methadone Pain, Addiction & Methadone A CHALLENGING INTERFACE METHADONE AND SUBOXONE OPIOID SUBSTITUTION CONFERENCE Objectives 2 Explore the interface between concurrent pain and addiction. Appreciate the challenges

More information

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES Pursuant to section 453-1.5, Hawaii Revised Statutes, the Board of Medical Examiners ("Board") has established guidelines for physicians with respect to the care and treatment of patients with severe acute

More information

Arkansas Emergency Department Opioid Prescribing Guidelines

Arkansas Emergency Department Opioid Prescribing Guidelines Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular

More information

Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest

Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest Treating Addiction in Chronic Pain Patients A Clinical Journey Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest Pain Addiction Kaiser Permanente Northwest 480,000 members

More information

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008 PRESCRITPION DRUG ABUSE: AN EPIDEMIC What is Addiction? By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Addiction is a primary, chronic disease

More information

The Chemical Coper Steven D. Passik, PhD

The Chemical Coper Steven D. Passik, PhD The Chemical Coper Steven D. Passik, PhD Associate Attending Psychologist Memorial Sloan Kettering Cancer Center New York, NY The Opioid Pendulum Avoidance Even dying people at risk of addiction Balance

More information

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION The Tennessee Board of Medical Examiners has reviewed the Model Policy Guidelines for Opioid Addiction Treatment

More information

Opioid Treatment Agreement

Opioid Treatment Agreement Opioid Treatment Agreement 1. I understand that my provider and I will work together to find the most appropriate treatment for my chronic pain. I understand the goals of treatment are not to eliminate

More information

MQAC Rules for the Management of Chronic Non-Cancer Pain

MQAC Rules for the Management of Chronic Non-Cancer Pain MQAC Rules for the Management of Chronic Non-Cancer Pain Effective January 2, 2012 246-919-850 Pain management Intent. These rules govern the use of opioids in the treatment of patients for chronic noncancer

More information

American Dental Association Providers Clinical Support System on Opioid Therapies Webinar

American Dental Association Providers Clinical Support System on Opioid Therapies Webinar American Dental Association Providers Clinical Support System on Opioid Therapies Webinar Friday, May 23, 2014 2:00 PM (CDT) Funding for this initiative was made possible (in part) by Providers' Clinical

More information

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges

More information

PRESCRIPTION PAINKILLER OVERDOSES

PRESCRIPTION PAINKILLER OVERDOSES IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky

More information

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15 ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB

More information

Tolerance and Dependence

Tolerance and Dependence Tolerance and Dependence Drug Tolerance is a decrease in the effect of a drug as a consequence of repeated exposure. Change over repeated exposures. Different effects may show different tolerance. Tolerance

More information

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate

More information

EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH. Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF

More information

Background & Significance

Background & Significance The Impact Of A Structured Opioid Renewal Clinic On Aberrant Drug Behavior Outcomes At A Northeastern VA Medical Center Salimah H. Meghani, PhD, MBE, CRNP Assistant Professor, University of Pennsylvania

More information

The latest in addiction medicine: What every nurse needs to know

The latest in addiction medicine: What every nurse needs to know CNA Webinar Series: Progress in Practice The latest in addiction medicine: What every nurse needs to know Monica Gregory Nurse Practitioner, Crosstown Clinic December 4, 2014 Canadian Nurses Association,

More information

William J. Lorman, PhD, MSN, PMHNP-NP, CARN-AP Vice President & Chief Clinical Officer, Livengrin Foundation, Inc. Clinical Asst. Professor, Graduate

William J. Lorman, PhD, MSN, PMHNP-NP, CARN-AP Vice President & Chief Clinical Officer, Livengrin Foundation, Inc. Clinical Asst. Professor, Graduate William J. Lorman, PhD, MSN, PMHNP-NP, CARN-AP Vice President & Chief Clinical Officer, Livengrin Foundation, Inc. Clinical Asst. Professor, Graduate Nursing Dept., Drexel University wlorman@livengrin.org

More information

2012 Carilion Prescription Drug Abuse Educational Forum 10/6/2014. Disclosure Statement

2012 Carilion Prescription Drug Abuse Educational Forum 10/6/2014. Disclosure Statement Protect Your Patients, Protect Your Practice: Precautions in Prescribing Controlled Substances Sarah T. Melton, PharmD,BCACP, BCPP,CGP,FASCP Psychiatry in the Mountains October 10, 2014 Objectives At the

More information

DrugFacts: Treatment Approaches for Drug Addiction

DrugFacts: Treatment Approaches for Drug Addiction DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please

More information

Information for Pharmacists

Information for Pharmacists Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl

More information

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification

More information

Southlake Psychiatry. Suboxone Contract

Southlake Psychiatry. Suboxone Contract Suboxone Contract Thank you for considering Southlake Psychiatry for your Suboxone treatment. Opiate Addiction is a serious condition for which you may find relief with Suboxone treatment. In order to

More information

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction

More information

MSD Guidelines for the Use of Controlled Substances for the Treatment of Pain

MSD Guidelines for the Use of Controlled Substances for the Treatment of Pain GUIDELINES MSD Guidelines for the Use of Controlled Substances for the Treatment of Pain To address the current epidemic of prescription drug abuse, your Medical Society has been working closely with the

More information

Drug Testing to Support Pain Management

Drug Testing to Support Pain Management NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of

More information

Managing Chronic Pain in Adults with Substance Use Disorders

Managing Chronic Pain in Adults with Substance Use Disorders Question from chapter 1 Managing Chronic Pain in Adults with Substance Use Disorders 1) What is the percent of chronic pain patients who may have addictive disorders? a) 12% b) 22% c) 32% d) 42% 2) Which

More information

The Brain, Behavior, and Addiction. Objectives. Advances in science have revolutionized our fundamental views of drug abuse and addiction.

The Brain, Behavior, and Addiction. Objectives. Advances in science have revolutionized our fundamental views of drug abuse and addiction. The Brain, Behavior, and Addiction Flo Hilliard University of Wisconsin-Madison Division of Continuing Studies Objectives Progress of science in addiction studies Why it is a brain disease Changing our

More information

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents Teen Misuse and Abuse of Alcohol and Prescription Drugs Information for Parents Terminology Misuse: Using a drug in a way in which it was not intended Example: Using a higher dose of medication than was

More information

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses

More information

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635

More information

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Division of Workers Compensation 04.01.2015 Background Opioids

More information

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.

More information

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania Dependence and Addiction Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania Overview Heroin and other opiates The disease of heroin addiction or dependence Effective

More information

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 ed #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 effects of alcohol in the brain 100 Top 30 698 heroin addiction 100

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the

More information

What Parents Need to Know

What Parents Need to Know What Parents Need to Know About Prescription Drug Abuse Office of District Attorney Jonathan W. Blodgett A Message From the District Attorney Prescription drug abuse is a growing problem. According to

More information

ADVISORY OPINION THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF CHRONIC PAIN

ADVISORY OPINION THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF CHRONIC PAIN Janice K. Brewer Governor Arizona State Board of Nursing 4747 North 7 th Street, Suite 200 Phoenix, AZ 85014-3655 Phone (602) 889-5150 Fax - (602) 889-5155 E-Mail: arizona@azbn.gov Home Page: http://www.azbn.gov

More information

Assessment and Diagnosis of DSM-5 Substance-Related Disorders

Assessment and Diagnosis of DSM-5 Substance-Related Disorders Assessment and Diagnosis of DSM-5 Substance-Related Disorders Jason H. King, PhD (listed on p. 914 of DSM-5 as a Collaborative Investigator) j.king@lecutah.com or 801-404-8733 www.lecutah.com D I S C L

More information

Understanding Your Pain

Understanding Your Pain Toll Free: 800-462-3636 Web: www.endo.com Understanding Your Pain This brochure was developed by Margo McCaffery, RN, MS, FAAN, and Chris Pasero, RN, MS, FAAN authors of Pain: Clinical Manual (2nd ed.

More information

What is Addiction? DSM-IV-TR Substance Abuse Criteria

What is Addiction? DSM-IV-TR Substance Abuse Criteria Module 2: Understanding Addiction, Recovery, and Recovery Oriented Systems of Care This module reviews the processes involved in addiction and what is involved in recovering an addiction free lifestyle.

More information

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse

More information

Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids

Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids Pik-Sai Yung, M.D. Staff Psychiatrist Center for Counseling at Walton Background and Rationale Alprazolam is

More information

Naltrexone and Alcoholism Treatment Test

Naltrexone and Alcoholism Treatment Test Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score

More information

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011 Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids

More information

Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management

Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management Dr. Barbara Krantz Medical Director Diplomate American Board of Addiction Medicine 1 Learning Objectives

More information

Treatment of Chronic Pain: Our Approach

Treatment of Chronic Pain: Our Approach Treatment of Chronic Pain: Our Approach Today s webinar was coordinated by the National Association of Community Health Centers, a partner with the SAMHSA-HRSA Center for Integrated Health Solutions SAMHSA

More information

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by

More information

5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279. Welcome

5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279. Welcome 5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279 Welcome Welcome to Starlight Behavioral Health Opiate Dependence program. At Starlight, we believe that addiction is

More information

a. positive vs. negative reinforcement b. tolerance vs. sensitization c. drug classes einforcement

a. positive vs. negative reinforcement b. tolerance vs. sensitization c. drug classes einforcement Drug Abuse (chapter 18) 1. Definitions iti a. positive vs. negative reinforcement b. tolerance vs. sensitization c. drug classes 2. Neural Mechanisms of Re einforcement a. mesolimbic dopamine system b.

More information

CONTROLLED SUBSTANCE CONTRACT

CONTROLLED SUBSTANCE CONTRACT CONTROLLED SUBSTANCE CONTRACT The purpose of this contract is to protect my access to controlled substances and to protect our ability to prescribe for you. The long-term use of substances such as opiates

More information

Drug and Alcohol Abuse Training revised: October 2015

Drug and Alcohol Abuse Training revised: October 2015 Drug and Alcohol Abuse Training revised: October 2015 FMCSA is considering going to a seven panel and possibly ten panel. Hair testing may also be acceptable. What is a Drug? A substance which

More information

Opioid Treatment Guidelines. Denis G. Patterson, DO University of Nevada, Reno 7/15/2015

Opioid Treatment Guidelines. Denis G. Patterson, DO University of Nevada, Reno 7/15/2015 Opioid Treatment Guidelines Denis G. Patterson, DO University of Nevada, Reno 7/15/2015 Opioid Treatment Guidelines Opioid Treatment Guidelines Chronic opioid therapy to treat chronic non-cancer pain (CNCP)

More information

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines

More information

Patients are still addicted Buprenorphine is simply a substitute for heroin or

Patients are still addicted Buprenorphine is simply a substitute for heroin or BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module VI: Myths About the Use of Medication in Recovery Patients are still addicted Buprenorphine is simply a substitute

More information

INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People

INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People Product No. 2002-L0424-004 INFORMATION BRIEF AUGUST 2002 U. S. D E P A R T M E N T O F J U S T I C E NDIC and Stockbyte Overview Prescription drugs, a category of psychotherapeutics that comprises prescription-type

More information

Understanding Addiction: The Intersection of Biology and Psychology

Understanding Addiction: The Intersection of Biology and Psychology Understanding Addiction: The Intersection of Biology and Psychology Robert Heimer, Ph.D. Yale University School of Public Health Center for Interdisciplinary Research on AIDS New Haven, CT, USA November

More information

Aberrant Drug-taking Behaviors: What Do We Know?

Aberrant Drug-taking Behaviors: What Do We Know? Aberrant Drug-taking Behaviors: What Do We Know? Steven D. Passik, PhD Associate Attending Psychologist Memorial Sloan Kettering Cancer Center New York, NY Where Will The Pendulum Stop? Avoidance Will

More information

About drugs. Psychoactive drugs. Drugs are substances that change a person s physical or mental state.

About drugs. Psychoactive drugs. Drugs are substances that change a person s physical or mental state. 1 About drugs Drugs are substances that change a person s physical or mental state. The vast majority of drugs are used to treat medical conditions, both physical and mental. Some, however, are used outside

More information

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive. Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.

More information

Opioid Agreement for Center for Pain Management S.C.

Opioid Agreement for Center for Pain Management S.C. Opioid Agreement for Center for Pain Management S.C. Patient Name: DOB: I am the patient named above. I have agreed to use pain medication as part of my treatment for chronic pain. I understand that these

More information

Table of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9

Table of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9 Table of Contents I. Introduction... 2 II. Summary... 3 III. Charts A. Total Drug Intoxication Deaths... 5 B. Opioid-Related Deaths... 9 C. Heroin-Related Deaths... 11 D. Prescription Opioid-Related Deaths...

More information

Introduction to Tolerance, Physical Dependence and Withdrawal

Introduction to Tolerance, Physical Dependence and Withdrawal Introduction to Tolerance, Physical Dependence and Withdrawal Carrie G Markgraf, MD, PhD Safety Assessment Merck Research Laboratories 1 Overview Definitions Addiction, psychological dependence, physical

More information

Painkiller addiction and pseudoaddiction in SCD (presentation 2 in a series of 3)

Painkiller addiction and pseudoaddiction in SCD (presentation 2 in a series of 3) Painkiller addiction and pseudoaddiction in SCD (presentation 2 in a series of 3) James Elander University of Derby j.elander@derby.ac.uk http://psychology.derby.ac.uk/staff/james_elander.html SCOOTER

More information

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us

More information

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,

More information

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion Angela Huskey, PharmD, CPE Case Bill is a 47 year old man with a history of low back pain and spinal stenosis Not a real

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: PDP IBT Inj - Vivitrol Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Opiate Antagonist Client: 2007 PDP IBT Inj Approval Date: 2/20/2007

More information

ADDICTIONS. BEHAVIOURAL Internet Shopping Work Sex Gambling Food. SUBSTANCE - RELATED Alcohol Drugs Medicine Tobacco

ADDICTIONS. BEHAVIOURAL Internet Shopping Work Sex Gambling Food. SUBSTANCE - RELATED Alcohol Drugs Medicine Tobacco ADDICTIONS BEHAVIOURAL Internet Shopping Work Sex Gambling Food SUBSTANCE - RELATED Alcohol Drugs Medicine Tobacco Addiction is a chronic, relapsing disease affecting the brains's reward, motivation and

More information

Joel Millard, DSW, LCSW Dave Felt, LCSW

Joel Millard, DSW, LCSW Dave Felt, LCSW Joel Millard, DSW, LCSW Dave Felt, LCSW 1. Provide an overview of the effectiveness of medication assisted treatment, to include a discussion of the different types of medications and how they are used

More information

DSM 5 SUBSTANCE USE DISORDERS. Ronald W. Kanwischer LCPC, CADC Professor Emeritus Department of Psychiatry SIU School of Medicine

DSM 5 SUBSTANCE USE DISORDERS. Ronald W. Kanwischer LCPC, CADC Professor Emeritus Department of Psychiatry SIU School of Medicine DSM 5 SUBSTANCE USE DISORDERS Ronald W. Kanwischer LCPC, CADC Professor Emeritus Department of Psychiatry SIU School of Medicine I have no financial relationships to disclose with regard to this presentation.

More information

Sample Patient Agreement Forms

Sample Patient Agreement Forms Sample Patient Agreement Forms Introduction This resource includes two sample patient agreement forms that can be used with patients who are beginning long-term treatment with opioid analgesics or other

More information

Heroin Addiction. Kim A. Drury RN, MSN

Heroin Addiction. Kim A. Drury RN, MSN Heroin Addiction Kim A. Drury RN, MSN Heroin use is on the rise in our area. Nearly every day the news media reports situations involving Heroin. According to the Substance Abuse and Mental Health Services

More information

Opiates Heroin/Prescription Steve Hanson Opiates Dates to 4,000 BC Mimics endorphin activity Natural - Opium, morphine, codeine Semi-synthetic- Heroin, Dilaudid Synthetics - Darvon, Demerol, Fentanyl Modern

More information

Substance Use: Addressing Addiction and Emerging Issues

Substance Use: Addressing Addiction and Emerging Issues MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population

More information

Addiction: Disease or Choice?

Addiction: Disease or Choice? Addiction: Disease or Choice? Presented by Michael Coughlin RN October 18, 2012 Introduced by Melanie Willows B.Sc. M.D. C.C.F.P. C.A.S.A.M. C.C.S.A.M. Assistant Professor University Of Ottawa Clinical

More information

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,

More information

Amphetamines Addiction

Amphetamines Addiction Introduction Amphetamines, which are classified as stimulants, work by using the dopamine reward system of the brain. When these drugs are used, the user s central nervous system is simulated which causes

More information

Iowa Governor s Office of Drug Control Policy

Iowa Governor s Office of Drug Control Policy Iowa Governor s Office of Drug Control Policy medicines or take them in a manner not prescribed, we increase the risk of negative effects. It is estimated that over 35 million Americans are ages 65 and

More information

Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion

Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures

More information

Considerations when Using Controlled Substances to Treat Chronic Pain

Considerations when Using Controlled Substances to Treat Chronic Pain Considerations when Using Controlled Substances to Treat Chronic Pain By Mary-Beth F. Plum, Pharm.D. Impact of Chronic Pain Acute pain is the body s response to environmental dangers, and it helps protect

More information

Update and Review of Medication Assisted Treatments

Update and Review of Medication Assisted Treatments Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment

More information

Opioid Addiction & Methadone Maintenance Treatment. What is Methadone? What is an Opioid?

Opioid Addiction & Methadone Maintenance Treatment. What is Methadone? What is an Opioid? Opioid Addiction & Methadone Maintenance Treatment Dr. Nick Wong MD, CCFP AADAC Edmonton ODP AADAC AHMB Concurrent Disorder Series September 13, 2007 1 What is Methadone? What is methadone? Synthetic opioid.

More information

Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center

Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center 1 in 4 Americans will have an alcohol or drug problems at some point in their lives. The number of alcohol abusers and addicts

More information

Medical marijuana for pain and anxiety: A primer for methadone physicians. Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015

Medical marijuana for pain and anxiety: A primer for methadone physicians. Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015 Medical marijuana for pain and anxiety: A primer for methadone physicians Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015 Conflict of interest statement No conflict of interest to

More information

Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse

Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse J E F F R E I T E R, P H D, A B P P H E A L T H P O I N T C O M M U N I T Y H E A L T H C E N T E R S S P R I N G 2 0 1 3 A

More information

Alcohol & Chemical Dependence. Chisoo Choi, M.D. Internal Medicine Consultant Brookhaven Hospital Tulsa, Oklahoma

Alcohol & Chemical Dependence. Chisoo Choi, M.D. Internal Medicine Consultant Brookhaven Hospital Tulsa, Oklahoma Alcohol & Chemical Dependence Chisoo Choi, M.D. Internal Medicine Consultant Brookhaven Hospital Tulsa, Oklahoma Objectives Increased awareness of alcohol and chemical dependence problems Hallmarks of

More information